Serum interleukin-6 as a neuroinflammatory biomarker across the spectrum of neurological disorders: a large-scale retrospective cohort study of 6,465 individuals - Top-Institutions - MDSpire

Serum interleukin-6 as a neuroinflammatory biomarker across the spectrum of neurological disorders: a large-scale retrospective cohort study of 6,465 individuals

  • By

  • Lingjun Zhao

  • Zhaoming Tang

  • Chengliang Zhu

  • May 13, 2026

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Renmin Hospital of Wuhan University
    Renmin Hospital of Wuhan University

    Wuhan, Hubei

    Key Differentiators

    • Neurology

  • #2

    Tanta Faculty of Medicine
    Tanta Faculty of Medicine

    Tanta, Gharbia

    Key Differentiators

    • Medicine

  • #3

    Tanta University Hospitals
    Tanta University Hospitals

    Tanta, Gharbia

    Key Differentiators

    • Medicine

  • #4

    MACS/WIHS Combined Cohort Study (MWCCS)
    MACS/WIHS Combined Cohort Study (MWCCS)

    Bronx, New York

    Key Differentiators

    • Endocrinology

  • #5

    tertiary care center in Spain
    tertiary care center in Spain

    Spain, N/A

    Key Differentiators

    • General Medicine

Original Source(s)

Serum interleukin-6 as a neuroinflammatory biomarker across the spectrum of neurological disorders: a large-scale retrospective cohort study of 6,465 individuals

  • by Lingjun Zhao, Zhaoming Tang, Chengliang Zhu

  • May 13, 2026

Related Content